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Environmental risk factors for dementia:
a systematic review
Lewis O. J. Killin1,2,3, John M. Starr1,2, Ivy J. Shiue1,4 and Tom C. Russ1,2,5,6*
Abstract
Background: Dementia risk reduction is a major and growing public health priority. While certain modifiable risk
factors for dementia have been identified, there remains a substantial proportion of unexplained risk. There is
evidence that environmental risk factors may explain some of this risk. Thus, we present the first comprehensive
systematic review of environmental risk factors for dementia.
Methods: We searched the PubMed and Web of Science databases from their inception to January 2016,
bibliographies of review articles, and articles related to publically available environmental data. Articles were included if
they examined the association between an environmental risk factor and dementia. Studies with another outcome (for
example, cognition), a physiological measure of the exposure, case studies, animal studies, and studies of nutrition
were excluded. Data were extracted from individual studies which were, in turn, appraised for methodological quality.
The strength and consistency of the overall evidence for each risk factor identified was assessed.
Results: We screened 4784 studies and included 60 in the review. Risk factors were considered in six categories: air
quality, toxic heavy metals, other metals, other trace elements, occupational-related exposures, and miscellaneous
environmental factors. Few studies took a life course approach. There is at least moderate evidence implicating the
following risk factors: air pollution; aluminium; silicon; selenium; pesticides; vitamin D deficiency; and electric and
magnetic fields.
Conclusions: Studies varied widely in size and quality and therefore we must be circumspect in our conclusions.
Nevertheless, this extensive review suggests that future research could focus on a short list of environmental risk
factors for dementia. Furthermore, further robust, longitudinal studies with repeated measures of environmental
exposures are required to confirm these associations.
Keywords: Dementia, Alzheimer’s disease, Environment, Epidemiology, Risk factors
Background
Dementia is a syndrome of cognitive and functional de-
cline, commonly occurring in later life as a result of neu-
rodegenerative and cerebrovascular processes beginning
earlier in the life course [1, 2]. It is a major and growing
public health concern with substantial increases projected
in the future, particularly in low-to-middle income coun-
tries [3–5]. Furthermore, there is now a consensus that a
substantial proportion of cases are potentially preventable
[6–9]. Preventing or, perhaps more realistically, delaying
the clinical onset of dementia would have a substantial ef-
fect on disease numbers [10–12]. It has been suggested
that approximately a third of Alzheimer’s dementia cases
could be attributed to seven potentially modifiable risk
factors: diabetes, midlife hypertension and obesity, smok-
ing, depression, cognitive inactivity, and low educational
attainment [13, 14]. Adding to this amount of risk ex-
plained estimates of population attributable fractions
derived from genetic factors [15], it is likely that a large
proportion of variance in dementia risk remains unex-
plained. Therefore, there is an urgent need to identify
further potentially modifiable risk factors for dementia.
There is evidence from studying geographical variation
in dementia rates that environmental risk factors may also
be important in the pathogenesis of dementia [16–19].
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Two previous reviews have reported on environmental
risk factors for Alzheimer’s disease: both concluded that
aluminium in drinking water and electromagnetic fields
were important and one also highlighted occupational ex-
posure to solvents and pesticides [20, 21]. However, both
these reviews focused on Alzheimer’s disease rather than
all-cause dementia and neither of them used robust, sys-
tematic review methodology and so may not have covered
all potentially important risk factors. Thus, we present the
first comprehensive systematic review on environmental
risk factors for dementia.
Methods
Information sources
We identified studies using three approaches. First, we
conducted an electronic search of the PubMed and Web
of Science databases from their start to January 2016
(Appendix 1). This search returned relevant primary stud-
ies and review articles. Second, we scrutinised bibliograph-
ies of included studies and review articles for additional
studies which had not been identified by the search. Third,
we reviewed a small number of hand-picked studies,
based on our knowledge of the literature from scrutiny of
articles related to publically available environmental data.
Search strategy
A shortlist of environmental factors was created based
on previous work investigating environmental risk factors
on health in general [22]. We also included factors not in-
cluded in the general list which we knew had been linked
to dementia risk, such as trace elements (for example, sel-
enium [23]). Thus, the list of environmental factors which
we searched for were air pollution, climate, ultraviolet ra-
diation, green space, industrial pollution, water quality,
noise pollution, low-frequency and radiofrequency radi-
ation, radon, nuclear facilities, contamination, and trace
elements.
Screening & eligibility
Records returned from the search were screened based
on titles and abstracts for suitability. Conference proceed-
ings, books and editorial publications were excluded. Of
the remaining studies, articles were then selected if they
reported an association (including null associations) be-
tween an environmental factor and any dementia.
The main exclusion criteria were: animal studies; single
case studies; studies where the exposure was a physio-
logical measure which could not be directly linked with
the environment, for example autopsy studies measuring
levels of trace elements in the brain or measuring serum
levels of a substance; studies with outcomes other than
clinical dementia, e.g. cognitive decline; studies of specific
symptoms or features (e.g. inflammation, oxidative stress)
of dementia rather than the full dementia syndrome;
studies where the exposure was solely nutritional; or
where insufficient data were reported in the paper. Since
we have recently published a systematic review and meta-
analysis on the association between rurality and urbanicity
on dementia [16], we did not consider this in the present
review. Relevant review studies were carefully examined
and additional primary articles not identified in the search
were included (see below for definition). However, if a
review reported multiple new studies, we included the
review as a single source of evidence, summarising its
findings rather than including every study individually
(for example, Loef and Walach, 2012 [24] included 101
individual studies). We refer to the review studies in
the main text and, where relevant, performed additional
focused searches to identify any more recent articles
which would have been included in these reviews. We also
reported the most recent report from studies, removing
any earlier report(s) (e.g., Rondeau et al., 2000 [25]).
Quality of evidence
Individual studies were appraised for quality. Large, pro-
spective longitudinal studies with a robust measure of
the risk factor in question at baseline and a clinical diag-
nosis of dementia were classified as being of quality level
A. High quality cross-sectional studies (i.e., a large sample
size with robust exposure and outcome measures) were
considered level B quality, and studies which did not reach
this level were considered level C quality. The total evi-
dence for an individual risk factor was synthesised to
conclude whether there is strong, moderate, or weak
evidence for an association (or lack of an association)
between the risk factor and dementia or whether there
is insufficient evidence to come to a conclusion. The
criteria for each level of strength are given in Table 1.
The reporting of this systematic review conforms to the
PRIMSA guidelines [26].
Results
The PRISMA diagram for the process of screening and
selecting records is shown in Fig. 1. From an initial total
of 6665 studies returned from the searches, after remov-
ing duplicates across the environmental factors, 4784
studies were screened for suitability. Of these, 60 were
identified as eligible for inclusion.
Table 2 shows the synthesised evidence from all studies
with a global judgement about the strength of the evi-
dence for an association from all published studies. The
environmental risk factors under consideration fall into
the following six groups: air quality, toxic heavy metals,
other metals, other trace elements, occupational-related
exposures, and miscellaneous environmental factors.
Tables 3, 4, 5, 6, 7 and 8 summarise individual studies
providing evidence for each risk factor in each category.
The tables are organised alphabetically by exposure
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with higher quality studies being reported first within
this grouping and included review studies last of all.
Air quality
Studies of the association between environmental risk fac-
tors in air and dementia are summarised in Table 3. Higher
levels of nitrogen oxides were observed to be associated
with increased dementia risk in two prospective cohort
studies: a 15 year prospective cohort study of 1806 healthy
men and women in Umeå, Sweden, and a retrospective co-
hort study of almost thirty thousand individuals identified
from the comprehensive Taiwanese health insurance data-
base passively followed up for a decade [27, 28]. However,
only the prospective study observed a dose–response pat-
tern of association (adjusted HR per 10 μg/m3 increase in
nitrogen oxides, 95 % CI 1.05, 0.98, 1.12) [27]. This study
grouped nitrogen oxides into the following cut-offs: 9, 17,
and 26 μg/m3. The other study only observed an increased
risk in the highest quartile and used the following cut-offs
for NO2 concentration: 6652.3, 8349.0, and 9825.5 parts
per billion [28]. The discrepancy in the pattern of observa-
tion observed in these two studies can be explained by the
fact that the former explored higher levels of NOx – the
highest cut-off from the latter study (~10 parts per million)
approximately corresponds to the lowest cut-off from the
former study (~10 mg/L ≡ μg/m3). The latter study also
investigated carbon monoxide concentration and found a
dose–response association with dementia risk for this ex-
posure (adjusted HR compared to the lowest quartile, 95 %
CI: 1.07, 0.92-1.25; 1.37, 1.19-1.58; 1.61, 1.39-1.85) [28].
Similar patterns were seen for men and women separately.
Environmental tobacco smoke was shown to be asso-
ciated with dementia risk in a cross-sectional study of al-
most 6000 people in five provinces of China [29]. These
investigators asked participants about exposure to envir-
onmental tobacco smoke at home, work, and in other
locations, duration of exposure as well as estimating cu-
mulative exposure. Rather than a clinical diagnosis, these
investigators used the GMS-AGECAT algorithm which
has been widely used in epidemiological studies, includ-
ing the MRC Cognitive Function and Ageing Studies
[30, 31]. Higher levels of exposure were associated with
an increased risk of severe dementia (O3-5) but not mod-
erate dementia (O1-2). The cut off for moderate dementia
used in this study showed only a positive predictive value
of 68.6 % but the cut off used for severe dementia per-
formed much better (88.1 %) [32]. The cumulative dose
analysis showed a dose–response association (adjusted
HR compared to a cumulative dose of zero for groups
>0-24, 25–49, 50–74, 75–99, ≥100, 95 % CI: 0.99, 0.76-
Table 1 Definitions of the strength of the reported association
between individual risk factors and dementia
Strong evidence for environmental risk factor
There is a reported association with dementia in the majority of
published papers.
Moderate or weak evidence for environmental risk factor
Although the reported association with dementia is not seen in the
majority of published papers, at least one published paper (or only
one) supports the association.
Weak evidence may come from a single, poorly designed study.
No evidence for environmental risk factor
No association with dementia has been revealed either due to a lack
of relevant research or the observed effect is not seen as significant.
Fig. 1 PRISMA diagram showing the selection of studies from search to inclusion
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Table 2 Quality of overall evidence for each environmental factor
Factor N Studiesa Overall Strength
Of Evidenceb
Direction Of
Associationc
C X R
Air
Nitrogen oxides (NOx) 2 Strong ↑
Carbon monoxide (CO) 1 Moderate ↑
Environmental tobacco smoke 1 Moderate ↑
Particulate matter (PM10&2.5) 1 1 Strong ↑
Ozone (O3) 1 1 Strong ↑
Toxic heavy metals
Arsenic 2 Moderate ↕
Lead 1 Weak ↑
Other metals
Aluminium 1 15 Moderate ↕
Calcium 1 Weak –
Cobalt 1 Weak –
Copper 2 1 Weak ↕
Iron 2 1 Weak ↕
Manganese 1 Weak ↑
Molybdenum 1 Weak –
Nickel 1 Weak –
Uranium 1 Weak –
Zinc 2 Weak ↕
Other trace elements
Fluoride 1 Weak ↑
Selenium 1 Moderate ↕
Silicon (and silica) 2 2 Strong ↕
Occupational
Aluminium
(occupational exposure)
1 3 Weak ↕
Defoliants/fumigants 1 Weak ↑
Diesel motor exhaust 1 Moderate –
Electromagnetic fields 1 Moderate ↕
Excessive noise 1 Weak ↓
Glues/adhesives 1 1 Weak ↕
Pesticides/fertilizers/herbicides/insecticides 5 2 2 Strong ↕
Lead (occupational exposure) 1 Weak –
Metals (occupational exposure) 1 Moderate ↑
Inks/dyes 1 Weak –
Paints/stains/varnishes 1 Weak –
Gasoline/fuels/oils 1 Weak –
Solvents/degreasers 2 1 1 Strong ↕
Liquid plastics/rubbers 1 Weak –
Vibratory tools 1 Weak –
Radiation 1 Weak ↑
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1.28; 1.15, 0.93-1.42; 1.18, 0.87-1.59; 1.39, 1.03-1.84;
1.95, 1.34-2.83). Also, all effect sizes were larger in
never smokers than when ex-smokers were included.
A prospective Taiwanese study following almost a mil-
lion people over ten years found an association between
baseline ozone but not particulate matter up to 2.5 μm
in diameter (PM2.5) and incident Alzheimer’s dementia
[33]. However, change in exposure to both pollutants
during follow up was associated with a two-to-three-fold
increased risk of incident AD. A final cross-sectional
study of 871 people in Taiwan also examined both par-
ticulate matter (PM10) and ozone concentration at the
participant’s home address, finding increased Alzhei-
mer’s dementia risk in the second and third tertiles of
PM10 concentrations (adjusted OR, 95 % CI: 1.68, 0.94-
3.00; 4.17, 2.31-7.54; Ptrend < 0.001) but only in the high-
est tertile of ozone concentrations (0.60, 0.33-1.09; 2.00,
1.14-3.50; Ptrend = 0.03) [34]. They found similar patterns
of association with vascular dementia.
Thus, the evidence for airborne environmental risk
factors for dementia is consistent in the direction of as-
sociation for all exposures and the overall strength of
evidence, while based on relatively few studies, is moder-
ate to strong.
Toxic heavy metals
Table 4 summarises the studies linking toxic heavy metals
to dementia risk. There were two studies of arsenic, one
of which was of grade-B quality and found no association
with dementia; the grade-C study found increased rates of
dementia in areas with higher soil arsenic levels but this
country-level simulation is less informative about risk fac-
tors in individuals [35, 36]. A case–control study with 129
people in each group found that an excess of people with
Alzheimer’s dementia were born in areas with higher than
average lead concentrations [37].
Overall, there was relatively little extant evidence for an
association between toxic heavy metals and dementia risk.
Other metals
Table 5 summarises the studies focused on other metals
and dementia risk. Aluminium was the most studied
metal, with sixteen studies investigating its relationship
with dementia including almost 22,000 people with de-
mentia. The only high quality study – a prospective co-
hort study of almost four thousand older adults in
south-west France (the PAQUID study [38]) – found
that levels of aluminium consumption in drinking water
in excess of 0.1 mg per day were associated with a doub-
ling of dementia risk and a three-fold increase in the risk
of Alzheimer’s dementia [39]. Of the remaining thirteen
moderate quality studies, six found an association be-
tween increased aluminium levels in drinking water and
increased dementia risk [40–45], four found no associ-
ation [37, 46–48], and one found a protective effect of
higher soil levels of aluminium [49]. In general, the lar-
ger studies showed a positive association and the smaller
studies showed a null effect.
A prospective cohort study compared calcium levels
in tap water with risk of developing Alzheimer’s dementia.
However, it is unclear if their not mentioning calcium as a
predictor means that they failed to examine it or if it did
not emerge from the models as an independent predictor.
A cross-sectional study found no association between co-
balt and dementia risk [37, 50]. Two case–control studies
and one review article summarising 101 studies consid-
ered copper and iron in relation to dementia [24, 37, 49].
The findings regarding copper were inconclusive. How-
ever, they reported that higher soil levels of iron were as-
sociated with an increased risk of dementia [37, 49]. The
review article was inconclusive [24].
An excess of people with Alzheimer’s dementia
were born in areas with higher than average levels of
manganese in a cross-sectional study [37]. The same
study found no evidence for an association between
molybdenum, nickel, uranium, or zinc with dementia
risk [37]. However, another study found that higher zinc
levels in the soil was associated with an increased risk of
Alzheimer’s dementia [49].
It is challenging to synthesise the published reports on
the association between metals and dementia, and the
published evidence for an individual element is often
weak and/or contradictory. However, there is at least some
evidence that calcium, cobalt, molybdenum, nickel, and
Table 2 Quality of overall evidence for each environmental factor (Continued)
Miscellaneous
Climate 1 Weak –
Electric and magnetic fields 1 2 Moderate ↕
Mobile phone use 1 Weak ↓
Vitamin D 3 1 Strong ↑
Water pH 1 Weak ↑
a
C cohort studies, X cross-sectional studies, R reviews. Studies can appear in multiple rows
bStrength of evidence is assessed according to the criteria outlined in Table 1
cIncreased levels of the exposure are associated with: ↑ an increased risk of dementia; ↓ a decreased risk of dementia; ↕ mixed results on dementia risk; and – no
substantial effect on dementia risk
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Table 3 Individual studies reporting the association between environmental risk factors in air and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Chang et al.,
2014 [28]
CO and NO2 Comprehensive National
Health Insurance database
in Taiwan – people aged
≥50 years.
29537 (NO2 29547) men and
women of whom 1718 (1720)
developed dementia
Retrospective cohort study: Cox PH
models.
Yearly average CO concentrations based
on location of clinic attended. Dementia
diagnoses were extracted from electronic
health records.
Highest vs lowest quartile of CO and
NO2 was associated with an increased
risk of dementia incidence (multivariable
adjusted HR, 95 % CI: 1.54, 1.34-1.77; 1.61,
1.39-1.85). Similar effects in men and
women.
A
Oudin et al.,
2015 [27]
Traffic-related air
pollution (NOx)
Participants from the
Betula study, randomly
sampled from the general
population residing in the
Umeå municipality
1,806 healthy men and women
of whom 302 developed
dementia
Prospective cohort study: Cox PH models.
Mean nitrogen oxide levels based on
baseline residence and dementia outcome
after 15 years.
Highest:lowest quartile of NOx revealed
an increased risk of incident dementia
(adjusted HR, 95 % CI 1.60, 1.02-2.10).
Similar results were observed in AD
and VaD.
A
Chen et al.,
2013 [29]
Environmental
Tobacco Smoke
Community dwelling adults
aged ≥50 years living in rural
or urban areas of five
provinces of China.
5921 men and women of
whom 626 had severe (O3-5)
and 869 moderate (O1-2)
dementia
Cross-sectional study. Smoking status and
ETS exposure (at home, work, and other
places) defined by self-report. Dementia
was diagnosed using the GMS-AGECAT
algorithm.
Multivariable-adjusted RR (95 % CI) for
exposure to ETS 0.96 (0.84, 1.09) for
moderate dementia and 1.29 (1.05,
1.59) for severe dementia. Risk of
severe dementia increased with
increasing duration and cumulative
dose, particularly in never smokers.
B
Jung et al.
2015 [33]
PM2.5 and O3 Individuals from Taiwan
entered into the longitudinal
health insurance database 2000
(LHID2000) aged ≥65 in 2001.
95,690 men and women of
whom 1399 developed AD.
Prospective cohort study: Cox PH models.
PM2.5 and O3 levels recorded at 70 Taiwan
Environmental Protection Agency
monitoring stations from 2000 to 2010.
These data were controlled for secondary
pollutants (CO, NO2 and SO2). AD was
identified when this was recorded at least
twice on the insurance database, based on
a physician diagnosis.
Baseline O3 was associated with an
increased risk of incident AD
(multivariable-adjusted HR per
interquartile range, 95 % CI: 1.06,
1.00-1.12) but baseline PM2.5 was
not (1.03, 0.95-1.11). Change in both
O3 and PM2.5 was associated with
increased AD risk (3.12, 2.92-3.33; 2.38,
2.21-2.56). This remained after
additionally adjusting for secondary
pollutants.
A
Wu et al.,
2015 [34]
PM10 and O3 249 AD patients, 125 VaD
patients (clinically diagnosed from
hospital clinics) and 497 controls
(from the elderly health check-up
program), all ≥60 years in Taiwan.
374 cases; 497 controls Cross-sectional study (case–control):
multiple regression. 12-year PM10 and
14-year ozone exposure were estimated
from spatiotemporal models based on
residential location.
Highest vs lowest tertile of PM10 and
ozone exposure was associated with
increased AD risk (adjusted OR,
95 % CI: 4.17, 2.31-7.54; 2.00, 1.14-3.50).
Similar results were found for VaD.
B
AD = Alzheimer’s dementia, CO carbon monoxide, ETS environmental tobacco smoke, GMS-AGECAT the Automated Geriatric Examination for Computer Assisted Taxonomy algorithm used with the Geriatric Mental State
interview (O = “organic” diagnosis from the AGECAT algorithm, levels 1–5), HR hazard ratio, NO2 nitrogen dioxide, O3 ozone, OR odds ratio, PH proportional hazards, PMx particulate matter up to x micrometres in size,
VaD vascular dementia
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Table 4 Individual studies reporting the association between toxic heavy metals and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Fox, 2014 [35] Arsenic Spring Valley Community,
Washington, District of
Columbia. Spring Valley
was built on a chemical
weapons lab which caused
arsenic to be distributed to
the surface soil.
Population of Spring Valley
2006 – 2010: 24,762
Comparison of annual average
age-adjusted mortality rates
(per 100,000) between Spring
Valley, Chevy Chase (2004 –
2010) and the US (2007).
No measure of arsenic
concentration is given for
these areas at these times.
AD mortality rate in Spring Valley
(22.8; CI 20.3 – 25.4) was comparable
to the Chevy Chase (22; CI 19 – 25)
and US (24.70) rates. No statistically
significant difference.
B
Dani, 2010 [36] Arsenic Secondary analysis of
country-level data.
Country-level data. Simulation. Slight increases in arsenic
concentration in soil were related to
exponential increases in dementia
rates at a country level.
C
Emard et al., 1994 [37] Lead The IMAGE Project
covering the population of
Saguenay-Lac-Saint-Jean
(SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples
of aquatic sediment were
analysed for geochemical
variables. AD cases were
identified from a registry.
15 individuals with AD were born in
areas with lower than average
concentration of lead; 49 were born
in areas with higher than average
concentrations. This difference was
statistically significant (P < 0.05).
B
AD Alzheimer’s dementia, CI confidence interval, SD standard deviation, SEM standard error of the mean
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Table 5 Individual studies reporting the association between other metals and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Rondeau et al.,
2009 [39]
Aluminium PAQUID: A community-based co-
hort of 3,777 elderly people aged
≥65 years in SW France.
1925 individuals of whom 461
developed clinically diagnosed
dementia (364 AD).
Prospective cohort study: Cox PH
models. Mean levels of aluminium in
drinking water over the previous
decade based on current residential
location was linked to incident
dementia over 15 years follow up.
Highest:lowest quartile of aluminium
in drinking water was associated
with an increased risk of dementia
and AD (multivariable-adjusted HR,
95 % CI: 2.34, 1.03-5.32; 3.04, 1.32-
6.97).
A
Flaten, 1990 [40] Aluminium The Norwegian population –
mortality data provided by the
Central Bureau of Statistics of
Norway.
5,642 male and 9,085 female
dementia deaths were recorded
1974–1983. The denominator
population is estimated at 40.6
million person-years. The population
of Norway was approximately 4
million people during this period.
Cross-sectional study: Pearson’s
correlation and relative risk. Four
water samples (one per season)
were collected in 1982–3 from 384
waterworks and analysed. Small
municipalities were aggregated to
regions of at least 10,000 inhabitants.
Dementia was ascertained from
death certification (any mention).
There was a correlation between the
aluminium content of drinking water
at municipality level and dementia
death rates in four time periods
from 1969–83 in men and women
(P < 0.025 and <0.005) but not with
PD or ALS death rates. This pattern
was less clear at county level.
B
Highest:lowest tertile of aluminium
concentration was associated with
an increased risk of dementia death
in men and women (RR, 95 % CI:
1.32, 1.20-1.46; 1.42, 1.32-1.54).
Forbes et al., 1995 [41] Aluminium Males from the Ontario
Longitudinal Study of Aging dying
between 1984 and 1991.
3161 patients with AD or young-
onset dementia.
Cross-sectional study: Poisson
regression. Water quality was based
on 30 years’ residential history.
Dementia was identified from death
certificates (underlying cause).
Highest:lowest tertile of aluminium
concentration was associated with
an increased risk of AD and AD plus
young-onset dementia (RR, 95 % CI:
2.42, 1.42-4.11; 1.96, 1.15-3.32). Effect
sizes were greater in analyses
restricted to individuals aged
≥75 years.
B
Total sample not stated.
Some models showed a lower risk of
dementia in the middle tertile of
aluminium concentrations compared
to the lowest.
Neri & Hewitt, 1991
[44]
Aluminium Patients discharged from general
hospitals in Ontario, Canada in
1986.
2344 people aged ≥55 years with a
diagnosis of AD or young-onset de-
mentia recorded and 2232 people,
matched for age and sex, with a
non-psychiatric diagnosis recorded.
Cross-sectional study (case–control).
Aluminium concentration in drinking
water based on residential location
was compared with dementia
diagnoses based on hospital
discharge statistics.
The authors report a dose–response
pattern of association (OR for
quartiles 2–4 compared to lowest,
95 % CI: 1.13, 0.55-2.29; 1.26, 0.61-
2.59; 1.46, 0.71-2.99) but all CIs (not
reported but calculated from data
reported in paper) include unity.
B
Gillette-Guyonnet et al.,
2005 [57]
Aluminium Toulouse subset of the EPIDOS
study cohort of women aged
≥75 years.
1462 women from one centre of
whom 60 developed clinically
diagnosed AD. 323 had normal
cognitive function and the
remainder were lost to follow up.
Prospective cohort study: logistic
regression. Water consumption
based on self-report (at baseline and
follow up) was combined with local
tap water composition data. Demen-
tia was clinically diagnosed.
It is not clear if aluminium
consumption was included in
logistic regression models and not
found to be a predictor of dementia
or if it wasn’t included.
B
Martyn et al., 1997 [46] Aluminium Participants were selected from CT
records of eight neuroradiology
centres in the UK.
A total of 872 men (106 AD, 99
other dementia, 226 brain cancer,
Cross-sectional study (case–control):
logistic regression. Average levels of
aluminium in drinking water based
There were no associations identified
between aluminium concentrations
over three time periods (from age
B
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Table 5 Individual studies reporting the association between other metals and dementia (Continued)
441 other disease of the nervous
system)
on residential history (after age
25 years) was related to diagnosis
based on hospital records.
25 years to diagnosis; from age
25 years to 10 years before
diagnosis; and the ten years
preceding diagnosis) with each of
the three comparison groups.
McLachlan et al., 1996
[43]
Aluminium Participants were selected from a
brain tissue bank in Ontario,
Canada.
296 participants had AD, 89 had
mixed dementia, 125 had no
histopathological abnormalities, and
170 had other conditions (HD,
schizophrenia, MS, multiple infarcts,
CJD, and other neurodegenerative
diseases).
Cross-sectional study (case–control).
Average aluminium concentrations
in domestic water supply of
residential location at death (10 year
residential history was available for a
subsample) were compared to
dementia status (neuropathologically
diagnosed).
Aluminium concentration >100 μg/L
compared to <100 μg/L was
associated with an increased risk of
AD and dementia (OR, 95 % CI: 1.7,
1.2-2.6; 1.7, 1.2-2.5).
B
Effect sizes were larger for the
subgroup analysis based on 10-year
residential history (2.6, 1.2-5.7; 2.5,
1.2-5.3).
Frecker, 1991 [42] Aluminium Mortality records in Bonavista Bay,
Newfoundland, 1985–86.
191 dementia deaths in 1985, 208
deaths in 1986
Cross-sectional study. Place of birth
of all individuals dying with
dementia was identified and
associated with drinking water
samples at those locations from
1986.
The area with the highest dementia
mortality (37.5 % in 1985 and 68.8 %
in 1986) also had the highest
aluminium concentrations in
drinking water. This association was
not assessed for statistical
significance, but was argued to not
be confounded by age, sex or place
of residence stated on death
certificate.
B
Emard et al., 1994 [37] Aluminium The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
44 individuals with AD were born in
areas with lower than average
concentration of aluminium; 41 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Forster et al., 1995 [47] Aluminium Patients were drawn from a
specialist service in the north of
England. Controls were randomly
selected from the general
population.
109 people with clinically diagnosed
young-onset AD and 109 age- and
sex-matched controls.
Cross-sectional study (case–control).
Aluminium levels in drinking water
were determined according to
residential history (longest residence
in the preceding 10 years plus
birthplace for a subset of 80 cases
and controls) at local authority
district level.
There was no evidence of an
association between aluminium
concentration in drinking water and
dementia risk (e.g. aluminium
>149 mg/L OR, 95 % CI: recent
residence 1.0, 0.41-2.43; birthplace
1.1, 0.38-3.35).
B
Taylor et al., 1995 [48] Aluminium Same cohort as Forster et al.,
1995 [47]
Water samples were obtained for
214 addresses of the 218 cases and
controls.
Cross-sectional study (case–control).
Aluminium concentration in water
samples drawn from the place of
residence at which they had lived
longest within 10 years prior to
onset of dementia (or equivalent
date for controls).
There were no differences in
aluminium concentrations in
samples for cases or controls (P =
0.60).
B
Gauthier et al., 2000
[107]
Aluminium Random sample of individuals
living in SLSJ aged ≥70 years from
Cross-sectional study (case–control).
Aluminium concentration in drinking
Of all variables involved in the
speciation of aluminium in drinking
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Table 5 Individual studies reporting the association between other metals and dementia (Continued)
the provincial health plan of
Quebec in 1994.
68 participants with clinically-
diagnosed AD and 68 age- and sex-
matched controls.
water was sampled four times in
1995–6 in 54 municipalities of SLSJ.
Long-term exposure was estimated
based on residential history.
water (total Al, total dissolved Al,
total monomeric Al, organic
monomeric Al, inorganic monomeric
Al, polymeric Al, as well as the main
monomeric inorganic forms) based
on recent and long-term exposure,
only recent exposure to monomeric
organic aluminium was associated
with AD at conventional levels (OR,
95 % CI 2.67, 1.04-6.90).
Shen et al., 2014 [49] Aluminium 26 provinces and 3 municipal
districts of mainland China.
Not specified. Cross-sectional study. Soil chemical
levels in 1990 were related to AD
mortality 1991–2000.
Higher aluminium levels in soil were
associated with reduced AD
mortality (highest:lowest group RR,
95 % CI: 0.267, 0.265-0.268).
B
Vogt, 1986 [45] Aluminium Mortality data from the Central
Bureau of Statistics (1969–1983)
and dementia patients within 112
psychiatric nursing homes (as
collected by Norwegian Institute
for Gerontology in 1982).
Not specified. Cross-sectional study. Drinking water
quality and acidification of lakes was
related to standardized dementia
mortality rates.
Highest:lowest zone of aluminium
concentration was associated with a
raised standardised dementia
mortality rate (per 10,000 inhabitants
per year: 48.3 vs 32.4). The effect size
was greater in women (59.4 vs 38.5)
than men (36.9 vs 26.1).
B
Wettstein et al., 1991
[108]
Aluminium Residents of two Zurich city
districts.
775 men and women aged 82–85
years who had lived in that area for
at least 15 years.
Cross-sectional study. Aluminium
concentrations were measured in
drinking water. The dementia
outcome was measured using the
truncated MMSE.
No significant difference was
observed between the participant
groups on mnestic or naming
subscores (P = 0.962 and P = 0.567).
C
Civita, Fiorucci, & Mie,
2001 [109]
Aluminium AD mortality in municipalities
within 20 km of Alba based on
national mortality statistics. Census
data were used as a reference
population.
Not stated. Cross-sectional study. A map of the
location of deaths with AD was
compared to levels of aluminium
released from 1 kg of clay at various
sampling sites.
They found an increased SMR in the
municipality compared to the
province or the whole of Italy. They
also noted that the areas with
highest dementia mortality had the
highest aluminium concentrations in
water.
C
Gillette-Guyonnet et al.,
2005 [57]
Calcium Toulouse subset of the EPIDOS
study cohort of women aged
≥75 years.
1462 women from one centre of
whom 60 developed clinically
diagnosed AD. 323 had normal
cognitive function and the
remainder were lost to follow up.
Prospective cohort study: logistic
regression. Water consumption
based on self-report (at baseline and
follow up) was combined with local
tap water composition data.
Dementia was clinically diagnosed.
Women who developed AD showed
a decrease in daily calcium intake at
follow up. It is not clear if calcium
consumption was included in
logistic regression models and not
found to be a predictor of dementia
or if it wasn’t included.
B
Emard et al., 1994 [37] Cobalt The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
21 individuals with AD were born in
areas with lower than average
concentration of cobalt; 20 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
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Table 5 Individual studies reporting the association between other metals and dementia (Continued)
Emard et al., 1994 [37] Copper The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
18 individuals with AD were born in
areas with lower than average
concentration of copper; 30 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Shen et al., 2014 [49] Copper 26 provinces and 3 municipal
districts of mainland China.
Not specified. Cross-sectional study. Soil chemical
levels in 1990 were related to AD
mortality 1991–2000.
Copper concentration correlated
with annual AD mortality after three
outlier provinces were removed (r =
0.449, P = 0.021).
B
Loef & Walach, 2012
[24]
Copper Systematic review of studies
relating copper to AD from 11
databases.
101 studies: Systematic review. Of relevant evidence that is
reviewed, the authors conclude that
“In summary, the current trials
provide no conclusive evidence that
depletion or supplementation of Cu
is beneficial for AD… [t]he specific
outcomes for Cu are more
conflicting; while evidence suggests
that the systemic Cu level is
increased in patients with AD,
further research is needed to define
the alterations of Cu in the brain
during AD.” (p.6).
-
2 meta analyses, 2 systematic
reviews, 11 RCTs, 2 prospective
studies, 3 cross-sectional studies, 45
case–control studies, 30 autopsy
studies,5 uncontrolled studies, 1 case
study.
Emard et al., 1994 [37] Iron The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
16 individuals with AD were born in
areas with lower than average
concentration of iron; 35 were born
in areas with higher than average
concentrations. This difference was
statistically significant (P < 0.05).
B
Shen et al., 2014 [49] Iron 26 provinces and 3 municipal
districts of mainland China.
Not specified. Cross-sectional study. Soil chemical
levels in 1990 were related to AD
mortality 1991–2000.
Higher iron levels in soil were
associated with increased AD
mortality (highest:lowest group RR,
95 % CI: 1.248, 1.245-1.251). Iron
concentration correlated with annual
AD mortality after three outlier
provinces were removed (r = 0.537,
P = 0.007).
B
Loef & Walach, 2012
[24]
Iron Systematic review of studies
relating iron to AD from 11
databases.
101 studies: Systematic review. “In summary, the current trials
provide no conclusive evidence that
depletion or supplementation of …
Fe is beneficial for AD… Fe has
been consistently found at elevated
levels in the brains of AD sufferers
by both autopsy and case–control
studies.” (p.6).
-
2 meta analyses, 2 systematic
reviews, 11 RCTs, 2 prospective
studies, 3 cross-sectional studies, 45
case–control studies, 30 autopsy
studies,5 uncontrolled studies, 1 case
study.
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Table 5 Individual studies reporting the association between other metals and dementia (Continued)
Emard et al., 1994 [37] Manganese The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
12 individuals with AD were born in
areas with lower than average
concentration of manganese; 35
were born in areas with higher than
average concentrations. This
difference was statistically significant
(P < 0.05).
B
Emard et al., 1994 [37] Molybdenum The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
29 individuals with AD were born in
areas with lower than average
concentration of molybdenum; 16
were born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Emard et al., 1994 [37] Nickel The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
27 individuals with AD were born in
areas with lower than average
concentration of nickel; 29 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Emard et al., 1994 [37] Uranium The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
10 individuals with AD were born in
areas with lower than average
concentration of uranium; 9 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Emard et al., 1994 [37] Zinc The IMAGE Project covering the
population of Saguenay-Lac-Saint-
Jean (SLSJ), Québec.
129 individuals with AD (clinically
diagnosed by standard medical
services) who were born in SLSJ.
Cross-sectional study: principal
components analysis. Samples of
aquatic sediment were analysed for
geochemical variables. AD cases
were identified from a registry.
29 individuals with AD were born in
areas with lower than average
concentration of aluminium; 30 were
born in areas with higher than
average concentrations. This
difference is not statistically
significant.
B
Shen et al., 2014 [49] Zinc 26 provinces and 3 municipal
districts of mainland China.
Not specified. Cross-sectional study. Soil chemical
levels in 1990 were related to AD
mortality 1991–2000.
Higher zinc levels in soil were
associated with increased AD
mortality (highest:lowest group RR,
95 % CI: 2.289, 2.275-2.303).
B
AD Alzheimer’s dementia, ALS amyotrophic lateral sclerosis, CI confidence interval, CJD Creutzfeld-Jakob Disease, CT computed tomography, HD Huntington’s disease, HR hazard ratio, MCI mild cognitive impairment,
MMSE mini-mental state examination, MS multiple sclerosis, PD Parkinson’s disease, PH proportional hazards, RCT randomized, controlled trial, RR relative risk, SD standard deviation, SEM standard error of the mean,
SMR Standardised Mortality Ratio
Figures in italics indicate data not reported but which have been calculated from data in the paper
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Table 6 Individual studies reporting the association between other trace elements and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Still & Kelley,
1980 [51]
Fluoride All first admissions of people aged
≥55 years to South Carolina
Department of Mental Health
hospitals from three counties who
had lived in that county for at least
10 years.
Case records for 160 patients
were examined and, based on
that evidence, 67 were
diagnosed with a primary
degenerative dementia, i.e. AD.
Cross-sectional study. Annual incidence of
dementia was calculated per county,
based on the admissions data. These were
then compared with fluoride
concentrations in public water supplies
(time of measurement is not given).
Horry County was reported to have
highest levels of fluoride (4.18 ± 0.19 mg/l)
compared to Anderson (0.49 ± 0.10 mg/l)
and York (0.61 ± 0.12 mg/l) Counties. It
also has the lowest calculated annual
incidence of dementia per 100,000
population (3.6; Anderson 20.8, York 17.1).
C
Loef, Schrauzer,
& Walach, 2011
[23]
Selenium Systematic review of studies relating
selenium to AD from 8 databases.
56 studies: 9 placebo-controlled,
4 prospective, 4 cross-sectional,
15 case–control, and 24 autopsy
studies.
Systematic review. One double-blind RCT is reported (PREAD-
VISE[52–54]) but this seems to have
subsequently converted into an
observational study.
-
A prospective cohort study is referred to
by citing a conference abstract [55];
subsequent reports do not focus on
selenium.[56]
Of 15 case–control studies, the authors
comment that “four studies reported
about increased levels of Se-concentration
or GPx-activity while the majority found
decreased levels, albeit non-significant in
some studies.” (p. 87).
Of the 24 autopsy studies, the authors
conclude that “the autopsy studies do not
yield a consistent picture of whether, how
and where in brain Se levels become
altered in subjects with AD.” (p. 87).
Gillette-Guyonnet
et al., 2005 [57]
Silica Toulouse subset of the EPIDOS study
cohort of women aged ≥75 years.
1462 women from one centre of
whom 60 developed clinically
diagnosed AD. 323 had normal
cognitive function and the
remainder were lost to follow up.
Prospective cohort study: logistic
regression. Water consumption based on
self-report (at baseline and follow up) was
combined with local tap water compos-
ition data. Dementia was clinically
diagnosed.
Low silica consumption in water (≤4 mg
vs >12 mg per day) was associated with
an increased risk of dementia
(multivariable-adjusted OR, 95 % CI: 2.74,
1.09-6.86). Women who developed AD
had lower silica intake at baseline and
showed a decrease in daily silica intake at
follow up.
A
Rondeau et al.,
2009 [39]
Silica PAQUID: A community-based cohort
of 3,777 elderly people aged
≥65 years in SW France.
1925 individuals of whom 461
developed clinically diagnosed
dementia (364 AD).
Prospective cohort study: Cox PH models.
Mean levels of silica in drinking water
over the previous decade based on
current residential location was linked to
incident dementia over 15 years follow
up.
Highest:lowest quartile of silica in drinking
water was associated with an increased
risk of dementia and AD (multivariable-
adjusted HR, 95 % CI: 1.33, 1.01-1.74; 1.33,
0.98-1.80).
A
Taylor et al.,
1995 [48]
Silica Same cohort as Forster et al., 1995
[47]
Water samples were obtained for
214 addresses of the 218 cases
and controls.
Cross-sectional study (case–control).
Aluminium concentration in water
samples drawn from the place of
residence at which they had lived longest
within 10 years prior to onset of dementia
(or equivalent date for controls).
There were no differences in silica
concentrations in samples for cases or
controls and no association between
increased levels of silica and dementia
(OR, 95%CI ≥3 mg/L 0.8, 0.34-1.83).
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Table 6 Individual studies reporting the association between other trace elements and dementia (Continued)
Martyn et al.,
1997 [46]
Silicon Participants were selected from CT
records of eight neuroradiology
centres in the UK.
A total of 872 men (106 AD, 99
other dementia, 226 brain cancer,
441 other disease of the nervous
system)
Cross-sectional study (case–control):
logistic regression. Average levels of
silicon in drinking water based on
residential history (after age 25 years) was
related to diagnosis based on hospital
records.
There were no associations identified
between silicon concentrations
consistently above 6 mg/L (compared to
lower levels) with each of the three
comparison groups (e.g. AD vs other
diagnoses (adjusted-OR, 95 % CI: 0.94,
0.39-2.26).
B
AD Alzheimer’s dementia, CI confidence interval, CT computed tomography, HR hazard ratio, OR odds ratio, PH proportional hazards, RCT randomized, controlled trial, RR relative risk, SD standard deviation, SMR
Standardised Mortality Ratio, UK United Kingdom
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Table 7 Individual studies reporting the association between occupational exposures and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Peters et al.,
2013 [60]
Aluminium (occupational
exposure)
Survey information
collected from miners
living in Kalgoorlie,
Western Australia. Data
collected in
1961,’62,’74,’75 and
2000.
1894 ever underground gold miners
linked with Western Australian
Registrar General’s Mortality Database
of whom 16 died with AD.
Retrospective cohort study: SMRs and
Cox PH models. Exposure to
aluminium dust ascertained by self-
report.
Aluminium dust inhalation was
associated with increased AD
mortality (SMR, 95 % CI: 1.38, 0.69-
2.75). There was also an association
between inhaled aluminium dust and
AD mortality in Cox models (HR, 95 %
CI: 2.76, 0.88-8.82).
B
Salib et al.,
1996 [61]
Aluminium (occupational
exposure)
Individuals referred to
a psychogeriatric unit
in Warrington, UK
198 AD, 194 other dementia, 176
unmatched controls.
Cross-sectional study (case–control).
Occupation based on self-report.
No association was found between
working in the aluminium industry
and AD (OR, 95 % CI: 0.98, 0.53-1.75).
This was also the case for all
dementias
B
Graves et al.,
1998 [58]
Aluminium (occupational
exposure)
Subsample of Kukull et
al.’s cohort [71].
89 AD and 89 matched controls. Cross-sectional study (case–control).
Aluminium exposure rated blind
based on occupational history.
There was an association between
ever exposure to aluminium and AD
(OR, 95 % CI: 1.46, 0.62-3.42) but not
in models which took into account
intensity, duration, or age at exposure.
B
Gun et al.,
1997 [59]
Aluminium (occupational
exposure)
Men and women
recruited from Sydney
hospitals 1986–1989.
170 probable or possible AD and 170
controls.
Cross-sectional study (case–control).
Aluminium exposure was derived
from an occupational interview.
Aluminium exposure was associated
with a reduced odds ratio of AD (OR,
95 % CI: 0.33, 0.01-4.16). This study
has very low statistical power because
only four cases and controls were
exposed. Probable and Possible AD
cases considered together.
C
Tyas et al.,
2001 [62]
Defoliants/fumigants The Manitoba Study of
Health and Aging –
random sample from
provincial health
insurance records.
694 cognitively-intact older adults
followed up for five years, during
which time 36 developed probable or
possible AD (clinically diagnosed).
Prospective longitudinal study.
Exposures based on self-report.
Exposure to defoliants/fumigants was
associated with an increased risk of
AD (multivariable-adjusted RR, 95 %
CI: 4.35, 1.05-17.90).
A
Koeman et al.
2015 [63]
Diesel motor exhaust (DME) The Netherlands
Cohort Study which
consisted of 120,852
individuals aged 55–69
years in 1986.
682 men and 870 women who had
died with non-VaD reported on their
death certificates over 17 years follow
up.
Case-cohort study: Cox PH models.
Exposures based on self-report.
Dementia status ascertained using
death certification. Person-years were
calculated from a randomly-selected
sub-cohort.
Exposure to DME compared to no
exposure was not associated with an
increased risk of non-VaD mortality in
men or women.
A
Koeman et al.
2015 [63]
Electromagnetic fields (ELF-
MF and electric shocks)
The Netherlands
Cohort Study which
consisted of 120,852
individuals aged 55–69
years in 1986.
682 men and 870 women who had
died with non-VaD reported on their
death certificates over 17 years follow
up.
Case-cohort study: Cox PH models.
Exposures based on self-report.
Dementia status ascertained using
death certification. Person-years at
risk were calculated from a
randomly-selected sub-cohort.
Low or high exposure to ELF-MF
compared to no exposure was not as-
sociated with an increased risk of
non-VaD mortality in men (adjusted
HR, 95 % CI 1.26, 1.01-1.57; 1.40, 0.92-
2.14) but not in women. Conversely,
an association was seen for electrical
shocks for women (1.25, 0.85-1.84;
11.1, 3.84-32.2) but not men.
A
The hazard associated with
cumulative ELF-MF exposure to
showed no trend (P = 0.09).
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Table 7 Individual studies reporting the association between occupational exposures and dementia (Continued)
Tyas et al.,
2001 [62]
Excessive noise The Manitoba Study of
Health and Aging –
random sample from
provincial health
insurance records.
694 cognitively-intact older adults
followed up for five years, during
which time 36 developed probable or
possible AD (clinically diagnosed).
Prospective longitudinal study.
Exposures based on self-report.
Occupational exposure to excessive
noise was associated with a
decreased risk of AD (multivariable-
adjusted RR, 95 % CI: 0.12, 0.02-0.96).
N.B. only one case was exposed to
excessive noise.
B
McDowell et al.,
1994 [66]
Glues and pesticides/
fertilizers
Canadian Study of
Health and Aging
based in 10 provinces.
258 people clinically diagnosed with
probable AD (less than three years
since onset of symptoms) and 535
age-matched controls (stratified by
study centre, community-/institution-
dweller and clinically confirmed to be
cognitively normal)
Cross-sectional study (case–control):
logistic regression. Risk factor
exposure gathered by questionnaire
self-report.
Occupational exposure to glues and
pesticides/fertilizers was associated
with an increased risk of AD
(multivariable-adjusted OR, 95%CI:
glues 1.80, 0.99-3.27; pesticides/
fertilizers 1.58, 0.81-3.10. Stratifying by
education showed higher risk in
those with less education.
B
Gauthier et al.,
2001 [64]
Herbicides, insecticides and
pesticides
1924 people aged
≥70 years old were
screened and
examined in the
Saguenay–Lac Saint-
Jean region (Québec,
Canada).
122 people clinically diagnosed with
AD and 122 age-matched controls
(±2 years). 67 case–control pairs hade
complete data and were included in
the models.
Cross-sectional study (case–control):
logistic regression. Exposure to
pesticides derived from residential
history and census data (1971–91) on
herbicide and insecticide spraying in
the area.
No increased risk of AD with exposure
to herbicides, insecticides or
pesticides (multivariable adjusted OR,
95 % CI: 1.07, 0.39-2.54); 1.62 (0.64-
4.11); 0.97 (0.38-2.41).
B
Santibanez et al.,
2007 [68]
Lead (occupational
exposure)
Systematic review of
studies linking
occupational exposures
and AD.
Twenty four studies: 3 cohort and 21
case–control studies.
Systematic review. “For lead exposure there are no data
supporting any association. All the
studies are case–control studies, with
a relatively low level of quality
according to our classification.” (p.
730)
-
Koeman et al.
2015 [63]
Metals (occupational
exposure)
The Netherlands
Cohort Study which
consisted of 120,852
individuals aged 55–69
years in 1986.
682 men and 870 women who had
died with non-VaD reported on their
death certificates over 17 years follow
up.
Case-cohort study: Cox PH models.
Exposures based on self-report. De-
mentia status ascertained using
death certification. Person-years at
risk were calculated from a
randomly-selected sub-cohort.
Low or high exposure to metals
compared to no exposure was
associated with an increased risk of
non-VaD mortality in men (adjusted
HR, 95 % CI 1.21, 0.84-1.74; 1.35, 0.98-
1.86) and women (4.55, 1.35-15.3; 1.78,
0.23-13.8).
A
The hazard associated with
cumulative exposure to metals
showed a significant trend (P = 0.01).
Hayden et al.,
2010 [65]
Pesticides The Cache County
study (Utah, USA).
3,084 individuals aged ≥65 years
without dementia followed up over
10 years during which time 500
people developed clinically-
diagnosed dementia (344 AD).
Prospective cohort study: Cox PH
models. Exposures based on self-
report. Follow-up conducted at 3, 7
and 10 years from baseline.
Pesticide exposure was associated
with an increased risk of dementia
(adjusted HR, 95 % CI 1.38, 1.09-1.76)
and AD (1.42, 1.06-1.91). A slightly
greater risk associated with
organophosphates for AD was
reported.
A
Baldi et al.
2003 [70]
Pesticides PAQUID cohort [110].
Male and female
residents of Gironde,
96 incident cases of AD from 1,507
contactable individuals between 5-
and 10-year follow-up.
Prospective cohort study. Occupational exposure to pesticides
was associated with an increased risk
of AD in men (adjusted RR, 95 % CI:
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Table 7 Individual studies reporting the association between occupational exposures and dementia (Continued)
France aged ≥65 in
1987.
2.4, 1.0-5.6). This was not the case for
other pesticide variables or in women.
Cumulative exposure to pesticides
was calculated based on job history.
AD was diagnosed by a neurologist.
Koeman et al.
2015 [63]
Pesticides The Netherlands
Cohort Study which
consisted of 120,852
individuals aged 55–69
years in 1986.
682 men and 870 women who had
died with non-VaD reported on their
death certificates over 17 years follow
up.
Case-cohort study: Cox PH models.
Exposure based on self-report. De-
mentia status ascertained using
death certification. Person-years at
risk were calculated from a
randomly-selected sub-cohort.
Exposure to any pesticides was not
associated with an increased risk of
non-VaD mortality in men or women.
The same pattern was seen when
disaggregating the effect of
insecticides, herbicides, and
fungicides in men. In women, high
exposure to herbicides and fungicides
was associated with an increased risk
of non-VaD mortality (adjusted HR,
95 % CI 5.27, 1.30-21.4; 2.83, 0.87-9.16).
A
The hazard associated with
cumulative exposure showed a
significant trend for all pesticides and
individual types (P = 0.01) but the
trend was reversed with increasing
exposure associated with a lower risk.
Povey et al.,
2014 [67]
Pesticides British farmers in the
1970s.
1,350 individuals born before 1958. Retrospective cohort study: logistic
regression. Exposure was based on
self-reported levels of
organophosphate exposure. Low dose
chronic exposure was defined as
handling organophosphate
concentrate and acute exposure as
having sought advice for pesticide
poisoning. Dementia was identified by
a screening questionnaire.
In people who had never sought
advice for pesticide poisoning,
handling pesticide concentrate was
not associated with dementia.
However, in those who had handled
pesticide concentrate, seeking advice
for pesticide poisoning was
associated with an increased risk of
dementia (adjusted OR, 95 % CI 4.27,
1.85-9.83).
B
Zaganas et al.
2013 [69]
Pesticides Review of studies
linking pesticide
exposure and
dementia.
Fourteen studies are reviewed (2 on
cognitive performance, 1 mild
cognitive dysfunction, 7 AD, 1 FTD, 2
VaD, and 1 PD).
Narrative review. Of the 7 AD studies, 5 demonstrated
an increased risk of AD (plus one
which did so weakly) and one
showed no association.
-
“Information from the literature [on
VaD] is scant; however, occupational
exposure to pesticides or fertilizers
conferred a two-fold increased risk of
developing vascular dementia in the
Canadian Study of Health and Aging.”
(p. 7).
“Due to the relative rarity of [FTD] at
the population level, pesticide
exposure has been studied as a
contributing factor to FTD onset in
relatively few studies and no
association was found.” (p. 7).
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Table 7 Individual studies reporting the association between occupational exposures and dementia (Continued)
Santibanez et al.,
2007 [68]
Pesticides Systematic review of
studies linking
occupational exposures
and AD.
Twenty four studies: 3 cohort and 21
case–control studies.
Systematic review. “For pesticides, research of greater
quality and prospective design found
increased and statistically significant
associations with AD. … The two case
control studies assessing risk
associated with pesticide exposure
and with GQI above the median
found evidence of smaller and non-
significant associations, supporting
the hypothesis that potential biases
might have affected these results,
decreasing the associations towards
the null.” (p. 729–31)
-
Tyas et al.,
2001 [62]
Pesticides/fertilizers, inks/
dyes, paints/stains/varnishes,
gasoline/fuels/oils, solvents/
degreasers, liquid plastics/
rubbers, glues/adhesives,
vibratory tools
The Manitoba Study of
Health and Aging –
random sample from
provincial health
insurance records.
694 cognitively-intact older adults
followed up for five years, during
which time 36 developed probable or
possible AD (clinically diagnosed).
Prospective longitudinal study.
Exposures based on self-report.
Other occupational exposures were
not associated with an increased risk
of AD (multivariable-adjusted RR, 95 %
CI: pesticides/fertilizers 1.45, 0.57-3.68;
inks/dyes 0.89, 0.28-2.81; paints/stains/
varnishes 1.21, 0.46-3.21; gasoline/
fuels/oils 0.79, 0.29-2.20; solvents/
degreasers 0.88, 0.31-2.50; liquid
plastics/rubbers 1.01, 0.12-8.38; glues/
adhesives 1.41, 0.49-4.05; use of
vibratory tools 1.03, 0.20-5.29).
A
Tyas et al.,
2001 [62]
Radiation The Manitoba Study of
Health and Aging –
random sample from
provincial health
insurance records.
694 cognitively-intact older adults
followed up for five years, during
which time 36 developed probable or
possible AD (clinically diagnosed).
Prospective longitudinal study.
Exposures based on self-report.
Occupational exposure to radiation
was associated with an increased risk
of AD (multivariable-adjusted RR, 95 %
CI: 3.57, 0.38-33.38). N.B. only one case
was exposed to radiation.
B
Kukull et al.
1995 [71]
Solvents Individuals aged
≥60 years recruited to
the Group Health
Cooperative in Seattle-
area clinics.
193 cases of AD and 243 unmatched
controls.
Cross-sectional study (case–control):
logistic regression. Risk factor
exposure was based on self-report.
Solvent exposure was associated with
an increased odds ratio of dementia
in men (adjusted OR, 95 % CI: 6.3, 2.2-
18.1) but not in women (0.6, 0.2-1.9).
In men, a significant effect of
exposure duration was observed.
B
Koeman et al.
2015 [63]
Solvents The Netherlands
Cohort Study which
consisted of 120,852
individuals aged 55–69
years in 1986.
682 men and 870 women who had
died with non-VaD reported on their
death certificates over 17 years follow
up.
Case-cohort study: Cox PH models.
Exposures based on self-report.
Dementia status ascertained using
death certification. Person-years at
risk were calculated from a
randomly-selected sub-cohort.
High exposure to any solvents
compared to no exposure was
associated with an increased risk of
non-VaD mortality in men (adjusted
HR, 95 % CI 1.20, 0.90-1.61) but not
women. High exposure to aromatic
solvents was associated with
increased non-VaD mortality in
women (3.46, 0.59-20.5) but not men.
High exposure to chlorinated solvents
was associated with increased risk in
men (1.33, 0.96-1.83) and women
(2.08, 0.60-7.14), as was low exposure
in men (1.25, 0.89-1.76).
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Table 7 Individual studies reporting the association between occupational exposures and dementia (Continued)
The hazard associated with
cumulative exposure to chlorinated
solvents showed a significant trend (P
= 0.01).
Santibanez et al.,
2007 [68]
Solvents Systematic review of
studies linking
occupational exposures
and AD.
Twenty four studies: 3 cohort and 21
case–control studies.
Systematic review. “For solvents, only two out of the 11
studies analysing this exposure found
a significant association with AD.” (p.
730)
-
AD Alzheimer’s disease, CI confidence interval, ELF-MF Extremely low frequency magnetic fields, FTD fronto-temporal dementia, HR hazard ratio; OR odds ratio, PD Parkinson’s disease, RR relative risk, VaD
vascular dementia
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Table 8 Individual studies reporting the association between miscellaneous exposures and dementia
Study Exposure Sample description N Methodology/design Finding Grade
Salib & Sharp,
1999 [72]
Climate Daily hospital admissions
from North Cheshire to a
single hospital. Dementia
cases were identified by
ICD-9 code 290.
189/2070 psychiatric
admissions during 1993 were
coded as being related to
dementia.
UK Meteorological Office data were collected
at Manchester airport (30 miles away) every
day.
There were no associations found between
weather parameters and hospital admissions of
people with dementia.
C
Huss et al.,
2009 [74]
Magnetic
field
exposure
(220–380 kV)
through
power lines
Swiss National Cohort from
2000–5. The study
population comprised 4.65
million individuals and
22,821,824 person-years.
29,975 dementia deaths
were recorded, including
9,228 AD deaths.
Prospective cohort study: Cox PH models.
Exposure was based on distance of place of
residence to the nearest power line and
duration of exposure (5, 10, or 15 years).
Dementia was ascertained from death
certification.
Proximity to power lines was associated with
an increased risk of dementia but this was not
statistically significant at conventional levels
(adjusted HR, 95 % CI closest:most distant
categories 1.23, 0.96-1.59). Longer duration
increased the magnitude of this association
(≥15 years at this place of residence 2.00, 1.21-
3.33).
A
Vergara et al.,
2013 [111]
Extremely
low
frequency
magnetic
fields
Systematic review of studies
of occupational exposure to
magnetic fields and
neurodegenerative disease.
20 AD and 9 dementia
studies.
Systematic review and meta-analysis. There was a small association between
occupational magnetic field exposure and AD
based on a meta-analysis (RR, 95 % CI 1.27,
1.15-1.40). There was no clear association with
dementia (1.05, 0.96-1.14).
-
Garcia et al.,
2008 72]
Extremely
low
frequency
electric and
magnetic
fields.
Systematic review and meta-
analysis
Fourteen studies: 9 case–
control, 5 cohort
Systematic review. Pooled cohort risk estimates (OR, 95 % CI 1.62,
1.16-2.27). Pooled case–control risk estimates
(2.03, 1.38-3.00, P = 0.004).
-
Schuez et al.,
2009 [75]
Mobile
phones
All mobile phone
subscriptions in Denmark,
1982–1995.
420,095 private mobile
phone subscribers of whom
532 were admitted to
hospital with a dementia
code during follow up.
Prospective cohort study. Mobile phone use
was derived from subscription records.
Dementia status was identified from hospital
admission records.
Mobile phone use was associated with a
decreased risk of being hospitalised with AD
(Standardized hospitalization ratio, 95 % CI 0.7,
0.6-0.9). Similar results were seen for VaD and
“other dementia”.
B
Afzal et al.,
2014 [76]
Vitamin D Danish general population
sample recruited to the
Copenhagen Heart Study at
baseline (1981 to 1983).
10,186 participants, of whom
418 developed AD and 92
developed to VaD.
Prospective cohort study: Cox PH models.
Baseline plasma vitamin D levels were related
to incident AD and VaD. Dementia status was
derived from diagnostic codes recorded on
the national Danish Patient Registry.
Lower plasma vitamin D levels were associated
with an increased risk of AD (HR, 95 % CI <25th
percentile [seasonally-adjusted] vs >50th 1.29,
1.01-1.66; P = 0.03). Similar findings were
reported for VaD (1.22, 0.79-1.87; P = 0.42) and
all dementia (1.27, 1.01-1.60; P = 0.02).
A
Littlejohns et al.,
2014 [78]
Vitamin D Healthy participants in the
US population–based
Cardiovascular
1658 adults followed up for
mean 5.6 years during which
time 171 developed
clinically-ascertained
dementia (102 AD).
Prospective cohort study: Cox PH models.
Serum vitamin D levels were measured at
baseline.
Being deficient (25-50nM) or severely deficient
(<25nM) in vitamin D was associated with an
increased risk of incident AD (multivariable-
adjusted HR, 95 % CI: 1.69, 1.06-2.69; 2.22, 1.02-
4.83; Ptrend = 0.008). Similar results were seen
for all-cause dementia (1.53, 1.06-2.21; 2.25,
1.23-4.13; Ptrend = 0.002).
A
Health Study.
Annweiler et al.,
2011 [77]
Vitamin D Toulouse subset of the
EPIDOS study cohort of
women aged ≥75 years.
40 participants, of whom 6
developed non-AD (and
4 AD) at clinical assessment
over 7 years follow up.
Prospective cohort study: logistic regression.
Baseline serum vitamin D was related to
incident non-AD dementia.
Vitamin D deficiency at baseline was
associated with an increased risk of non-AD
dementia (adjusted OR, 95 % CI 19.57, 1.11-
343.69; P = 0.042).
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Table 8 Individual studies reporting the association between miscellaneous exposures and dementia (Continued)
Wilkins et al.,
2006 [79]
Vitamin D Participants recruited from
greater metropolitan St
Louis, MO by the
Washington University AD
Research Center.
40 people with clinically
diagnosed mild AD and 40
without dementia.
Cross-sectional study (case–control): logistic
regression and general linear model. Serum
vitamin D levels were measured.
Vitamin D status was not associated with AD
(multivariable-adjusted OR, 95 % CI: deficient
vs sufficient 2.80, 0.64-12.28; insufficient vs
sufficient 1.78, 0.61-5.19). Vitamin D status was
associated with CDR sum of boxes (P = 0.0468);
and the Short Blessed Test (P = 0.0077) but not
others tests.
B
Frecker,
1991 [42]
Water pH Mortality records in
Bonavista Bay,
Newfoundland, 1985–86.
191 dementia deaths in
1985, 208 deaths in 1986
Cross-sectional study. Place of birth of all
individuals dying with dementia was identified
and associated with drinking water samples at
those locations from 1986.
The area with the highest dementia mortality
(37.5 % in 1985 and 68.8 % in 1986) also had
the lowest pH of drinking water (5.2). This
association was not assessed for statistical
significance, but was argued to not be
confounded by age, sex or place of residence
stated on death certificate.
B
AD Alzheimer’s disease, CI confidence interval, HR hazard ratio, OR odds ratio, PH proportional hazards, UK United Kingdom, VaD vascular dementia
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uranium are not associated with an increased risk of de-
mentia, but this is often based on minimal evidence. One
prospective study and the larger cross-sectional studies
tend to support an association between aluminium and
dementia risk [39–41, 44].
Other trace elements
Table 6 shows the studies investigating links between
other trace elements and dementia. A cross-sectional
study extrapolated from the medical records of 160 people
to estimate annual dementia incidence and found the area
with the highest fluoride concentrations in public water
supplies had the lowest incidence [51]. Selenium has been
the focus of a number of studies. The included review art-
icle [23] referred to a randomised, controlled trial of
selenium supplementation to reduce dementia risk, the
PREADVISE trial, but this seems to have converted
into an observational study and is yet to report on selen-
ium levels [52–54]. The review also referred to a confer-
ence abstract reporting a prospective cohort study [55],
but subsequent reports do not focus on selenium [56]. In
general, this review article reported mixed findings from
15 case–control studies and 24 autopsy studies [23].
One cross-sectional study found no differences in aver-
age levels of silicon in drinking water between a group of
people with Alzheimer’s dementia and several neurological
control groups [46]. On the other hand, two prospective
cohort studies found an association between higher levels
of silica in drinking water and dementia incidence [39, 57].
However, a case–control study did not corroborate these
findings [48].
The evidence for other trace elements is again mixed
and generally weak in strength.
Occupational-related exposures
Table 7 summarises the individual studies relating occupa-
tional exposures to dementia risk. Four studies investi-
gated occupational exposure to aluminium in relation to
dementia [58–61]. These tended to be small with conse-
quently low statistical power. Their results were mixed.
The prospective Manitoba Study of Health and Aging
studied a variety of exposures but the only robust associ-
ation they found was an increased risk of dementia in rela-
tion to self-reported exposure to defoliants/fumigants
[62]. The same study reported null associations in all
other exposures studied, apart from a protective effect
of excessive noise and increased risk associated with
radiation exposure. However, in both these cases, only
one person with dementia had been exposed to noise or
radiation and so there is very limited statistical power. A
case-cohort study of 1552 people dying with non-vascular
dementia found no association between exposure to
diesel motor exhaust fumes and dementia but mixed
evidence for extremely low frequency magnetic fields
or electric shocks [63]. Two reviews concluded that ex-
posure to pesticides was associated with an increased risk
of dementia which was corroborated by the prospective
Canadian Study of Health and Aging, Cache County
Study, the PAQUID study, and to some extent a retro-
spective British study of farmers but not by the Manitoba
study or a case–control study from Québec; a study from
the Netherlands had mixed findings [62–70]. A systematic
review found no support for an association between occu-
pational exposure to lead and dementia and mixed evi-
dence (predominantly null) between solvent exposure and
dementia [68]. A case–control study from the USA found
an association between solvent exposure and AD, at least
in men [71]. However, a case-cohort study from the
Netherlands found mixed associations between solvents
and dementia, perhaps reflecting the diversity of chemicals
described as solvents [63].
The evidence linking occupational exposures and de-
mentia is frequently weak. Aside from the mixed evidence
for solvents, the strongest evidence is for exposure to
pesticides, but even findings in that literature are mixed.
However, there seems to be no published evidence sug-
gesting that occupational exposure to diesel motor ex-
haust, lead, inks/dyes, paints/stains/varnishes, gasoline/
fuels/oils, liquid plastics/rubbers, or vibratory tools
affect dementia risk.
Miscellaneous environmental factors
Table 8 summarises studies linking miscellaneous envir-
onmental exposures and dementia. One study reported
no association between climate and dementia admissions
[72]. Two systematic reviews examined low and extremely
low frequency electric and magnetic fields and, while
the evidence is mixed, there seems to be an association
with dementia risk and this was corroborated by a pro-
spective study in Switzerland which found that living close
to power lines for over 15 years was associated with a
doubling of Alzheimer’s disease mortality (but not the oc-
cupational study mentioned above [63]) [73, 74]. Its find-
ings are difficult to interpret, but a prospective study in
Denmark found that mobile phone subscription was
associated with a decreased risk of subsequent hospital
admission with dementia [75]. Three high quality pro-
spective studies (including 11,884 people of whom 691 de-
veloped dementia) examined the association between
vitamin D and dementia and all found that lower vitamin
D levels at baseline were associated with an increased risk
of developing dementia [76–78]. However, this finding
was not corroborated by a small case–control study (40 in
each group) of people with mild dementia [79]. Finally,
one study noted that the area with the highest dementia
mortality had the lowest drinking water pH [42].
Out of the miscellaneous exposures considered in this
section, there seems to be strong evidence that vitamin
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D deficiency is associated with increased risk of demen-
tia and moderate evidence implicating electric and mag-
netic fields. There is no published evidence supporting
any role for weather parameters in dementia risk.
Discussion
Main findings
In summary, we found moderate evidence for air pollution
exposures being related to dementia risk, particularly nitro-
gen oxides, particulate matter, and ozone. There was little
evidence that toxic heavy metals, or indeed most metals,
influence dementia risk, apart from aluminium – where
larger, better quality studies suggested an association.
Other than silicon, there was little evidence for other trace
elements affecting dementia risk, though selenium remains
an interesting element. Of the occupational exposures,
there was little strong evidence, but the evidence suggests
that exposure to some pesticides and, possibly, metals may
affect dementia risk. Finally, there was strong evidence
for vitamin D deficiency being associated with raised
dementia risk and moderate evidence for electromagnetic
fields, though this complicated exposure requires some
unpicking.
Limitations of the review and risk of bias within and across
studies
The broad search and systematic methodology of this re-
view is likely to have identified all the available literature.
Our exclusion of studies without dementia as their out-
come resulted in the exclusion of high quality studies
examining the association between environmental risk
factors and, for example, cognition or brain structure
[80, 81]. Such studies may shed some light on the patho-
genesis of dementia since cognitive or brain changes are
important features of dementia but they are not specific
to this syndrome. We excluded papers measuring levels
of a particular substance (often trace elements) in brain
areas or in serum since these physiological changes
could not be directly linked to environmental exposure.
Our other exclusion criteria (case studies, animal or nutri-
tional studies) are unlikely to have resulted in the exclu-
sion of relevant papers or introduced bias. As mentioned
above, we did exclude papers examining the effect of rur-
ality or urbanicity since we have previously reviewed this
literature and found in a meta-analysis an increased risk
of dementia (particularly Alzheimer’s dementia) in rural
areas, particularly living in rural areas early in life [16].
One unavoidable bias is that, despite the projected in-
crease in dementia rates occurring disproportionately in
low-to-middle income countries [4], the majority of the
research was conducted in high-income countries.
One of the major challenges in trying to synthesise
such a broad selection of papers is the diversity of
methodologies used. When considering Bradford Hill’s
criteria for inferring a causal association (strength,
consistency, specificity, temporality, biological gradient,
plausibility, and coherence), one clearly cannot satisfy
the temporality criterion with a cross-sectional study,
and thus a longitudinal study will provide more robust
evidence for the role of a risk factor in the pathogenesis
of dementia [82]. Since many of the included studies
are cross-sectional, it is often not possible to infer a
causal relationship. However, attrition in longitudinal
studies can be non-random which can introduce selection
bias [83]. Furthermore, no study measured exposures at
more than one time point (though some measured the
average exposure in a period), which will give a more ac-
curate picture of true exposure over time and is essential
in order to test whether there are critical or sensitive pe-
riods within the life course [84].
The fact that a number of exposures were only studied
in a single study (see Table 2) also weakens support for
them as it is impossible to examine the consistency of the
association in multiple studies. However, exposures which
were investigated in more than one study were also mea-
sured in a variety of ways, sometimes with variable quality.
For example, many exposures were inferred from an
address. This may be reasonable when it is not possible
to measure an individual’s exposure directly, but the
timing of measurement of the exposure is crucial, as
will be discussed below. One strength of this approach
is that it allows cumulative exposure to be estimated,
given the participant’s residential history. A more ro-
bust measure of an individual’s exposure is direct meas-
urement. This will clearly make a study more costly
and will also not solve the problem of the timing of the
exposure. Less robust, but frequently used for occupa-
tional exposures, in particular, is self-report. This does
avoid the problem of temporality as different points in
the life course can be covered, but will be limited in detail
and prone to recall bias [85]. Finally, direct measurement
of levels of a substance in the brain is likely to be the most
accurate, but is also the most difficult to link to dementia
risk – particularly for substances present in health – and
thus these studies were excluded from the presence of the
review. Alzheimer’s disease in the brain and the overt clin-
ical symptoms of Alzheimer’s dementia are parallel, related
phenomena [9] and the fact that approximately a third of
people dying without dementia can have moderate or se-
vere Alzheimer’s disease in their brains further complicates
the interpretation of autopsy studies [86]. Returning to
Bradford Hill’s criteria, a number of included studies
grouped their exposures into multiple categories, allowing
the exploration of a biological gradient in any association
observed – for example nitrogen oxides [27] – which can
strengthen any inference of a causal relationship.
Where possible, we reported the most-adjusted model
in a particular study. Most studies adjusted for age and
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sex and some for other relevant known risk factors for
dementia such as educational attainment or comorbidity
but adjustment beyond that was highly variable. The
possibility of residual confounding still remains.
There was a similar diversity of methodologies (and
diagnostic criteria) used to identify people with dementia
and it is important to consider whether any of these may
introduce bias. Most robust is direct clinical assessment
of individuals (often combined with a preliminary
screening phase to minimise costs), either specifically for
a research project or sourced from medical records.
Two-phase screening seems to provide an accurate meas-
ure of dementia [87], but screening non-participation may
introduce selection bias [88]. A substantial number of
studies used dementia mortality as their outcome. This
has previously been criticised [89], but more recent
studies suggest that dementia reporting is improving,
for example 72 % of a memory clinic cohort had de-
mentia correctly diagnosed on their death certificates
[90]. Importantly, death certification of dementia did not
seem to be related to premorbid intelligence or area-level
deprivation in that study (unpublished results available
from the author on request). Another study using multiple
sources from electronic health records to identify cases of
dementia found that death certificates alone identified 83 %
of the total number of cases identified by any source [17].
An additional important point is the adequacy of controls
in case–control studies – there was some variability in
the extent of matching with people with dementia.
Since we know that dementia is a condition which is
affected by risk and protective factors throughout the life
course [1], when the exposure is measured is crucial.
Within life course epidemiology, there are three models
of the association between a risk factor and an outcome:
accumulation of risk, sensitive periods, and critical pe-
riods [91, 92]. Sensitive periods refer to a period of the
life course when an exposure has a greater effect than
other times. A critical period is the only time when a
particular exposure has its effect; it does not affect risk if
encountered at a different point in life. Crucially for
dementia – which is now indisputably considered a
condition of the life course [93] – the exposure in a
study must be measured sufficiently early in life plaus-
ibly to be involved in the pathogenesis of a condition
which begins years or even decades before the clinical
onset of symptoms [94]. For example, we have found evi-
dence above for an association between air pollution and
dementia but it is not clear at what stage of life exposure
is important. A recent study found a biomarker which has
been proposed for Alzheimer’s disease (reduced cerebro-
spinal fluid levels of Aβ1–42 [95]) in children in Mexico
City who had been exposed to high levels of air pollution
in utero and throughout their life compared to controls
[96]. The issue of timing of exposures has been rather
neglected by the published literature on potential environ-
mental risk factors for dementia and should be considered
in much richer detail in the future.
Comparison with previous literature
To the best of our knowledge, this is the first compre-
hensive systematic review of environmental risk factors
for dementia. A review article was recently published on
environmental risk factors for Parkinson’s disease and
Alzheimer’s disease [20]. However, this article did not
take the systematic approach or focus on dementia of
the present review – the author included an extremely
broad range of risk factors, including some environmen-
tal risk factors alongside clinical, lifestyle, and dietary
factors. The findings of that review generally agreed with
ours and it concluded that there was robust evidence for
an increased risk of Alzheimer’s disease in relation to ex-
posure to pesticides and that there was weak evidence
for an increased risk in relation to levels of aluminium
in drinking water and electromagnetic fields.
An older review summarised the literature relating to
a number of risk and protective factors and concluded
that there was evidence that occupational exposure to
solvents, pesticides, and electromagnetic fields as well
high levels of aluminium in drinking water were hazardous
[21]. A brief review article from around the same time con-
sidered young-onset Alzheimer’s dementia and highlighted
a number of deficiencies in the literature, many of which
remain, which frequently consisted of small studies with
limited measurements of environmental data, particularly
in relation to the life course and what would now be re-
ferred to as the ‘preclinical’ period [97].
Implications
As mentioned above, if a modifiable environmental risk
factor for dementia could be identified and modified, the
implications for public health, the economic cost of de-
mentia, and individuals’ suffering could be profound. We
have reported, albeit with many caveats, a short list of
environmental factors which may be related to dementia
risk – air pollution (all types); aluminium; silicon; selenium;
pesticides; vitamin D; and electric and magnetic fields –
and it is reasonable to speculate about possible mecha-
nisms which might underlie these associations, if they
were to prove causal. These mechanisms could be ex-
amined in more detail using methodologies such as
Mendelian randomization [98].
Air pollution has been shown to be associated with re-
duced cerebral blood flow [99] and seems to be neuro-
toxic [100]. As shown above, brain changes – including
cognitive changes and biomarkers – can be identified in
children living in areas with high levels of air pollution
compared to controls [96]. Aluminium has been found in
amyloid plaques and neurofibrillary tangles (pathological
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features of Alzheimer’s disease) and, in rat models, alu-
minium intake increases amyloid expression [101, 102].
Furthermore, it has been suggested that relatively small
amounts of aluminium could be neurotoxic and levels
could accumulate selectively in certain brain tissues [103].
Silica may reduce absorption or increase excretion of alu-
minium [39]. Copper could be implicated in the pathogen-
esis of Alzheimer’s disease in a number of ways, including
promoting Aβ aggregation and hyperphosphorylation and
aggregation of tau [104]. The role of selenium in human
physiology is complex [105] and it is involved in multiple
molecular pathways relevant to the development of
Alzheimer’s disease [23]. Pesticides form a heterogeneous
group but some seem to be neurotoxic. Organophosphates,
for example, may disrupt cholinergic neurotransmission
through inhibition of acetylcholinesterase [69]. Chronic
exposure to some pesticides has been linked to multiple
neurological conditions, though specific mechanisms
remain unclear. Vitamin D has numerous effects rele-
vant to the pathogenesis of Alzheimer’s disease, includ-
ing stimulating macrophages to clear amyloid plaques,
reducing amyloid-induced cytotoxicity, as well as main-
tenance of cerebrovascular function [78]. Electric and
magnetic fields have been proposed to affect the brain
in a variety of mechanisms – including oxidative stress,
apoptosis and necrosis of neurons, and even cytogenetic
effects – but no firm mechanistic link with dementia has
been made [73, 106]. It can be seen that several of these
putative risk factors could act through multiple routes and
it may become even more difficult to disentangle the rela-
tive importance of Alzheimer’s disease pathology and
cerebrovascular disease in causing clinical dementia.
Conclusions
In conclusion, the published evidence concerning specific
environmental risk factors for dementia is generally not
strong. However, there seems to be little role for most
metals or other trace elements, occupational exposure to
lead, inks/dyes, paints/stains/varnishes, gasoline/fuels/oils,
liquid plastics/rubbers, vibratory tools, or climate in deter-
mining dementia risk. There is at least moderate evidence
consistently supporting air pollution, aluminium, silicon,
selenium, pesticides, vitamin D, and electromagnetic fields
as putative environmental risk factors for dementia. More
and better research is needed and we suggest that this
shortlist should form the initial focus of attention.
Appendix 1
Search syntax for PubMed and Web of Science
Alzheimer’s OR dementia AND
1. air pollution (air pollut*)
2. climate
3. UV radiation
4. green space
5. industrial pollution (indust* pollut*)
6. drinking water
7. noise pollution
8. low-frequency radiation
9. radiofrequency radiation
10.radon
11.nuclear facilities (nuclear facil* OR nuclear power)
12.contamination (contaminat*)
13.trace elements
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